Press Releases

"Efficacy and Safety of Almonertinib Mesilate VS Platinum-Containing Dual-Agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic...

World Environment Day on June 5 is one of the main media for the United Nations to promote global environmental awareness and raise public awareness a...

Recently, the clinical trial application of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or the "Company") for HS-20094, an independ...

On June 2, Synexis, a partner of Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or the "Company"), announced that the innovative antif...

Recently, Jiangsu Hansoh Pharmaceutical Group Co., Ltd. ("Hansoh Pharma" or "Company") received the Notice of Approval for Clinical Trial of Drug from...

Recently, the Chinese Diabetes Society ("CDS") released the Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2020 Edition) ("C...

 Recently, the marketing approval application of Ameile (Almonertinib Mesilate Tablets), Class 1 innovative drug independently developed by Jiangsu Ha...

Recently, "Create Excellence in China with Ameile - 2nd CSCO Hansoh Pharma Lung Cancer Precision Diagnosis and Treatment Forum" was held simultaneousl...